The rapid evolution of Big Data holds the potential of generating greater insights for key commercial decisions within the biopharmaceutical industry. Despite this, the biopharma industry is still only in nascent stages when it comes to big data utilization for informing critical commercial operations.
The complexity of the healthcare ecosystem combined with the inherent costs and other difficulties associated with big data utilization pose a huge challenge to most companies in leveraging Big Data. Best Practices, LLC conducted a benchmarking study to review the best practices, winning strategies and current and future trends for big data utilization across the commercial function.
The study, “Big Data in Pharma: Current & Future Trends for Big Data Utilization Across Commercial Function” provides benchmarks around the most valuable data types and sources for strategic commercial decisions; governance policies and leadership; and the most impactful data producers, dissemination channels and targets. Biopharmaceutical organizations can devise/revamp their big data strategies by analyzing the big data trends, insights and benchmarks revealed in the study.
Read More at: http://www.best-in-class.com/bestp/domrep.nsf/products/big-data-in-pharma-current-future-trends-for-big-data-utilization-across-commercial-function?OpenDocument